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Who Were Those Guys?
Fellows-in-training know a lot. They study for boards and cram in the information that they
guess will be on the examination. But, do they know anything about what cardiology was
before they were born, and do they care? A rather senior interventional cardiologist colleague
of mine said that the interventional fellows do not even know who Andreas Gruentzig was!
Even as they expertly evaluate the hemodynamic significance of ischemia-producing lesions and
deftly deploy modern stents to alleviate the obstruction, they seem to assume that this is the
obvious solution to the patient’s problem without reflecting on how foreign this concept was
throughout almost all of the history of medicine. I was recently asked to write a brief history
of coronary revascularization for a European publication (1). Here are some of the “Cliff’s
Notes.”
The concepts of Galen regarding circulation were based on speculation in the second
century, but were embraced until the renaissance when William Harvey dispelled them in the
17th century. One of the first to accurately link angina pectoris with coronary obstruction was
Edward Jenner (1749 to 1823), the discoverer of a vaccination for smallpox. Sir James
Mackenzie (1853 to 1925) advocated the ischemic origin of angina and its relevance to
obstructed coronary arteries. So, finally, we knew the cause of angina but were far from having
the most logical solution, namely coronary revascularization. Until there were tools for seeing
inside the patient (thank Röntgen), and until methods to visualize the coronary (thank
Forssman, Klein, Cournand, and Richards for catheterization, and finally Sones for coronary
visualization), there was no way to conceive of the solution of coronary obstructions. When
coronary imaging became available, some ideas sprung to light. First, Vineberg placed the
bleeding internal mammary artery into a tunnel dug in the myocardium to await collaterals to
form, connecting with the coronary arteries. This was rapidly replaced by direct coronary
revascularization with Rene Favaloro of the Cleveland Clinic leading the way. Others had
previously performed vascular surgery on the coronary arteries. Ake Senning of Zurich
introduced patch grafting, and perhaps the first bypass was done by Garrett and DeBakey in
1964 for complications of coronary endarterectomy. Dudley Johnson of Milwaukee was among
the most aggressive in placing multiple grafts, and George Green of New York performed
direct internal mammary artery grafting to the left anterior descending coronary artery. The
1970s was the decade of extensive growth of coronary revascularization by surgery, and the
conflicts then were between surgeons and enthusiastic cathing cardiologists on one side, and
more conservative cardiologists on the other. The CASS (Coronary Artery Surgery Study)
enrolled 780 stable patients to surgery or medical therapy. When the results were presented in
Anaheim, I remember the enthusiasm of the conservative group when the overall results did
not show a survival benefit with surgery. This trial, however, did show which patients
benefited and they were those with the most extensive coronary disease and worst left
ventricular function. Other trials, such as the VA-Cooperative Trial and the European
Coronary Surgery Study, further emphasized the benefit of coronary artery bypass graft surgery
for patients with more extensive disease. Throughout the 1970s, symptomatic patients in these
studies and many registries were experiencing significant relief of angina, and bypass surgery
flourished.
The idea of an endovascular approach to coronary revascularization developed for peripheral
vascular disease. Charles Dotter of Portland, Oregon, observed improvement in claudication in
patients with iliac disease after diagnostic angiography with fairly bulky catheters. This led him
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316to use larger coaxially delivered catheters to further
enlarge the lumen, and the Dotter technique was born. It
was a crude method, and to some he was a controversial
enthusiast, so the procedure died out in the United
States. In Europe, especially Germany, the procedure had
advocates including Eberhard Zeidler of Nuremberg.
Zeidler’s work was observed by a young physician with an
interest in vascular disease and a fertile imagination.
Andreas Gruentzig, realizing the Dotter technique would
only open the obstructed peripheral artery to the size of
the catheter, conceived of a small catheter that, when in
the obstructed artery, would become big. The balloon
catheter was born. In 1977, following animal
experimentation and very limited work on patients
undergoing bypass surgery, he performed the first
coronary angioplasty. The traffic to Zurich to observe the
technique grew and, in 1980, Andreas immigrated and
joined our lab at Emory to teach, develop, and evaluate
the technique. I have previously relayed much of that
story in this page, and therefore will not repeat it here.
Only to say to those who do not know who Gruentzig
was, he was the father of your subspecialty. Among the
many who have moved our specialty forward are John
Simpson, who advocated the guidewire method for
delivering the balloon catheter, and the engineers from
several companies who subsequently made the
cumbersome guidewire the fine instrument we have today.
The most dramatic clinical presentation for coronary
revascularization has been ST-segment elevation
myocardial infarction. Raymond Erbel and Geoffrey
Hartzler were pivotal in perfecting this method. Ourmain limitation of endovascular therapy was acute artery
occlusion due to vascular and plaque recoil and dissection.
Stenting had several advocates, but Ulrich Sigwart’s work
on the first coronary stent used in human arteries must be
recognized. Many other dramatic contributions to our
specialty are worthy of learning about.
These tools and many others that have been added are
now commonplace in practice, and like the jet plane I will
board tomorrow, many seem to fly effortlessly. But, for
the pioneers who first conceived of the opportunity to try
something that had not previously been done, the feeling
was more like the Wright brothers preparing to take off.
It is said that we should study history so as not to repeat
it. I say there are many ideas that initially could not grow
to maturity, but with improved technology, now may. In
the beginning, coronary pressure gradient was the main
measure of successful percutaneous transluminal coronary
angioplasty (today, think fractional flow reserve). Study
the history of your specialty, not to repeat it, but to
improve it.
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